Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced in oligodendrocytes (175 nCPM) | 1.00 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 80 | 0.91 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 9548
Sealed predictions
- PIK3C2B in oligodendrocytes, braak-0.06 (p 0.873) → -0.74 (p 0.024)receipt 9555
- PIK3C2B in dopamine neurons, braak-0.46 (p 0.209) → -0.69 (p 0.038)receipt 9556
Swarm cases
receipt 9556: PIK3C2B in dopamine neurons, braak
- power
- full sample -0.52 (p 0.027, n 18), 95% CI -0.79 to -0.07. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.51 (p 0.031, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.62 (p 0.0060, n 18). not the mix.
- skeptic
- leave-one-out range -0.63 to -0.46, sign flips 0; without severely affected donors -0.52 (p 0.027, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PIK3C2B in dopamine neurons.
case closed: nothing better to follow up.
receipt 9555: PIK3C2B in oligodendrocytes, braak
- power
- full sample -0.43 (p 0.077, n 18), 95% CI -0.75 to +0.05. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.44 (p 0.070, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.38 (p 0.118, n 18). could be the mix.
- skeptic
- leave-one-out range -0.56 to -0.35, sign flips 0; without severely affected donors -0.43 (p 0.077, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PIK3C2B in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts